Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromes
Annika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, Corinna Strupp, Maximilian Seidl, Martina Rudelius, Sascha Dietrich, Ulrich Germing, Norbert Gattermann · 2026
Read Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromes by Annika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, Corinna Strupp, Maximilian Seidl, Martina Rudelius, Sascha Dietrich, Ulrich Germing, Norbert Gattermann (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13253648.txt.
Description
Annika Kasprzak and colleagues weigh iron as a warning sign in bone marrow disease in this 2026 study. Myelodysplastic syndromes are marrow disorders where blood making falters, and iron often piles up in the marrow even before transfusions begin.
The team analysed 3,748 patients at first diagnosis. About half already had raised marrow iron, which tracked with worse anaemia and higher blood ferritin, a stored-iron marker. Extra marrow iron shortened survival mainly in the subgroup with more immature cells, where it was the strongest single survival predictor after adjustment. Age and disease subtype dominated overall, with ferritin also independent. The authors back checking iron at diagnosis.
Catalog record
| CREATOR | Annika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, Corinna Strupp, Maximilian Seidl, Martina Rudelius, Sascha Dietrich, Ulrich Germing, Norbert Gattermann |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30689 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |